Carol Pollock

Carol Pollock AO FAHMS is a medical researcher specialising in kidney health and disease. She is a Clinical Professor of Medicine at the University of Sydney, Northern Clinical School, Kolling Institute of Medical Research.^[1] Her research interests also include obesity, diabetes, cardiovascular disease, healthy ageing and lifespan, employing animal models and cellular and molecular techniques.^[1] She is the Chair of Kidney Health Australia and was the Chair of Medicine Royal North Shore Hospital in 2011 to 2016. ^{[2] [3]}

Pollock was awarded the Officer of the Order of Australia on 14 June 2021^[2] for 'distinguished service to medical research, education and science, to nephrology, and to clinical practice and governance.' ^[2]

In 2015, she was elected as a fellow of Australian Academy of Health and Medical Sciences. ^[4]

• Koshino, A., Mahaffey, K., Pollock, C., Hansen, M., Wada, T., Heerspink, H., Neuen, B., Oshima, M., Toyama, T., Hara, A., Jardine, M., et al (2024). Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial. Kidney International Reports, 9(2), 347-355.

• Kolovos, P., Pollock, C. (2024). Diabetic kidney disease A new era in therapeutic management. Medicine Today, 25(1-2), 47-51.

Scholia has a profile for Carol Pollock (Q91886684).